Mandatory Hiatoplasty in Sleeve Gastrectomy for Gastro-Esophageal Reflux Disease
Launched by INSTITUTO MEXICANO DEL SEGURO SOCIAL · Mar 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a specific surgical procedure called mandatory hiatoplasty during gastric sleeve surgery, which is used for weight loss. The main goal is to find out how often patients develop gastroesophageal reflux disease (GERD) after this surgery and to compare complication rates, including GERD, among patients. Participants will also fill out a questionnaire after the surgery to share how they feel about their quality of life.
To be eligible for this study, you need to be at least 18 years old and have certain types of obesity. The study is open to all genders, and you must have had gastric sleeve surgery with hiatoplasty at a well-known hospital in Tijuana that specializes in weight loss surgeries. If you're interested in participating, you can expect to share your experiences and help researchers understand the impact of this surgery on patients' lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 18 years of age.
- • Gender indistinct.
- • Overweight, obesity grade I, II, III, super obesity or super-super obesity.
- • Underwent gastric sleeve with hiatoplasty for obesity management at a high volume Tijuana hospital dedicated to bariatric surgery.
- Exclusion Criteria:
- • Patient records with incomplete information.
About Instituto Mexicano Del Seguro Social
The Instituto Mexicano del Seguro Social (IMSS) is a prominent public institution in Mexico, dedicated to providing comprehensive healthcare services and social security to its members. Established to enhance public health and welfare, IMSS plays a pivotal role in the advancement of medical research and clinical trials aimed at improving patient outcomes. By facilitating innovative studies, IMSS contributes to the development of new therapies and treatments, ensuring that the healthcare system remains at the forefront of scientific progress and responds effectively to the health needs of the population.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guadalajara, Jalisco, Mexico
Patients applied
Trial Officials
José Aldo Guzmán-Barba, MD, PhD
Study Chair
ALO Bariatrics. Gobernador Ibarra 9721, Zona Cacho, 22044, Tijuana, Baja California, México.
Alejandro López-Ortega, MD, PhD
Study Director
ALO Bariatrics. Gobernador Ibarra 9721, Zona Cacho, 22044, Tijuana, Baja California, México.
Helmut Heribert, MD, PhD
Principal Investigator
ALO Bariatrics. Gobernador Ibarra 9721, Zona Cacho, 22044, Tijuana, Baja California, México.
Isaac Esparza Estrada, MD, PhD
Study Chair
ALO Bariatrics. Gobernador Ibarra 9721, Zona Cacho, 22044, Tijuana, Baja California, México.
Sergio Jiram Vazquez-Sánchez, MD
Study Chair
Unidad de Investigación Biomédica 02, Unidad Médica de alta especialidad, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44329, Mexico
Alejandro González-Ojeda, MD, PhD
Study Chair
Unidad de Investigación Biomédica 02, Unidad Médica de alta especialidad, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44329, Mexico
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported